Prime Gene Therapeutics
Fengtai
About Prime Gene Therapeutics
Prime Gene Therapeutics is committed to becoming a pharmaceutical company. They focus on new drug discovery, R&D, and commercialization in inflammatory diseases and external use. They are also developing and industrialization of innovative drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $41.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2025)
- Website: en.primegene.net
- Phone: 010-83141848
Industries & Categories
Emergency Medicine, Health Care, Medical
Canonical: https://fsome.com/organization/prime-gene-therapeutics-85742 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.